| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA718661 | F | Effective dose that gave 50 percent inhibition of sarcoma 180 tumor growth in ddY mice | Mus musculus | 9 | cell-based format | Scientific Literature | ||
| 2. | ALA729607 | F | Optimal dose against sarcoma 180 tumor in ddY mice | Mus musculus | 16 | cell-based format | Scientific Literature | ||
| 3. | ALA729611 | F | Optimal dose towards sarcoma 180 cells, inoculated subcutaneously to the axillary region of ddY mice | Mus musculus | 17 | cell-based format | Scientific Literature | ||
| 4. | ALA730237 | F | Treated versus control value of tumor volume was measured in ddY mice | Mus musculus | 16 | cell-based format | Scientific Literature | ||
| 5. | ALA728814 | F | Tumor volume of sarcoma 180 cells which were inoculated intravenously to the axillary region of ddY mice, after treatment | Mus musculus | 17 | cell-based format | Scientific Literature | ||
| 6. | ALA746250 | F | Compound was tested in vivo for antitumor activity against murine sarcoma 180 in mice at 0.25 mg/kg dosage and efficacy is expressed as T/C (mice were implanted subcutaneously with tumor cells and the drug was dosed intravenously) | Mus musculus | 8 | organism-based format | Scientific Literature | ||
| 7. | ALA801460 | F | Concentration required to inhibit replication of S-180 cell lines by 50% after 72 hr incubation | Mus musculus | 9 | cell-based format | Scientific Literature | ||
| 8. | ALA801461 | F | Cytotoxicity in S-180 (murine sarcoma) cell was determined. | Mus musculus | 1 | cell-based format | Scientific Literature | ||
| 9. | ALA801462 | F | In vitro inhibitory concentration against growth of mouse sarcoma 180 (S-180) cells | Mus musculus | 5 | cell-based format | Scientific Literature | ||
| 10. | ALA801463 | F | In vitro inhibitory concentration against growth of mouse sarcoma 180 (S-180) cells; Inactive | Mus musculus | 6 | cell-based format | Scientific Literature | ||
| 11. | ALA801464 | F | Growth inhibitory effect of compound when administered at dose of 1.5 mg/kg/day given in the schedule of 1,2,3,4,7 day against Sarcoma S-180 tumor transplanted in male JRC mice at eleventh day was determined; No effect | Mus musculus | 2 | organism-based format | Scientific Literature | ||
| 12. | ALA801465 | F | Growth inhibitory effect administered at dose of 1.5 mg/kg/day given in the schedule of 1,2,3,4,7 day against Sarcoma S-180 tumor transplanted in male JRC mice at eleventh day was determined | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 13. | ALA801466 | F | Growth inhibitory effect administered at dose of 1.5 mg/kg/day given in the schedule of 1,2,3,4,7 day against Sarcoma S-180 tumor transplanted in male JRC mice at fourteenth day was determined | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 14. | ALA801467 | F | Growth inhibitory effect administered at dose of 1.5 mg/kg/day given in the schedule of 1,2,3,4,7 day against Sarcoma S-180 tumor transplanted in male JRC mice at fourteenth day was determined; No effect | Mus musculus | 2 | organism-based format | Scientific Literature | ||
| 15. | ALA801468 | F | Growth inhibitory effect administered at dose of 5.0 mg/kg/day given in the schedule of 1,2,3,4,7 day against Sarcoma S-180 tumor transplanted in male JRC mice at eleventh day was determined | Mus musculus | 2 | organism-based format | Scientific Literature | ||
| 16. | ALA801469 | F | Growth inhibitory effect administered at dose of 5.0 mg/kg/day given in the schedule of 1,2,3,4,7 day against Sarcoma S-180 tumor transplanted in male JRC mice at fourteenth day was determined | Mus musculus | 2 | organism-based format | Scientific Literature | ||
| 17. | ALA803231 | F | Growth inhibitory effect when administered at dose of 2.0 mg/kg/day given in the schedule of 1,2,3,4,7 day against Sarcoma S-180 tumor transplanted in male JRC mice at fourteenth day was determined | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 18. | ALA802555 | F | Growth inhibitory effect when administered at dose of 2.0 mg/kg/day given in the schedule of 1,2,3,4,7 day against Sarcoma S-180 tumor transplanted in male JRC mice at fourteenth day was determined; ND= No data | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 19. | ALA802556 | F | Growth inhibitory effect when administered at dose of 5.0 mg/kg/day given in the schedule of 1,2,3,4,7 day against Sarcoma S-180 tumor transplanted in male JRC mice at fourteenth day was determined | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 20. | ALA801676 | F | Ratio of ILS tested compound/quinocarcin against murine sarcoma S-180 tumor cell line implanted subcutaneously in mice and the compound administered intravenously at a dose of 10 mg/kg on days 1-5. | Mus musculus | 1 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!